The 20 Best Aplasia Cutis Congenita Doctors Near Me in Ann Arbor, MI

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Dr. Jacobson completed residency in New York and a fellowship in pediatricophthalmology at the Kellogg Eye Center. His interests include medicaleducation and pediatric glaucoma. He is currently one of the associatemedical student clerkship directors and manages patients with pediatricglaucoma at the University of Michigan. Dr. Jacobson is rated as an Advanced provider by MediFind in the treatment of Aplasia Cutis Congenita. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Stickler Syndrome, Axenfeld-Rieger Syndrome, Microphthalmia, Trabeculectomy, and Vitrectomy. Dr. Jacobson is board certified in Ophthalmology.

Cagri Besirli is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Besirli is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Stickler Syndrome, Vitrectomy, and Trabeculectomy. Dr. Besirli is board certified in Ophthalmology.

Emily Eton is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Eton is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Retinal Detachment, Endophthalmitis, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Otana Jakpor is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Jakpor is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. Her clinical expertise encompasses Strabismus, Meibomianitis, Esotropia, and Hyphema. Dr. Jakpor is board certified in Ophthalmology.

Mark Hannibal is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Hannibal is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. He is also highly rated in 166 other conditions, according to our data. His clinical expertise encompasses Aase Syndrome, CHARGE Syndrome, Cockayne Syndrome Type 2, and Hennekam Syndrome. Dr. Hannibal is board certified in Clinical Genetics & Genomics.

Dr. Pritchard is a Michigan native who returned to the University of Michigan to join the faculty here in 2019 after completing her pediatrics and genetics residencies and biochemical genetics fellowship. She enjoys care of complex patients with rare genetic diseases. Dr. Pritchard is active in medical education as Program Director for the Medical Biochemical Genetics Fellowship program and Associate Program Director for the Medical Genetics and Genomics training programs.Outside of work, Dr. Pritchard enjoys cooking, reading, hiking, and spending time with her husband and two daughters. Dr. Pritchard is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. She is also highly rated in 149 other conditions, according to our data. Her clinical expertise encompasses Microcephaly Deafness Syndrome, Propionic Acidemia, Delayed Growth, and Cohen Syndrome.

Christian J. Vercler, M.D. is a faculty member in the Section of Plastic Surgery in the Department of Surgery with a joint appointment in the Department of Neurosurgery at Michigan Medicine. He serves as Co-Chief of the Clinical Ethics Service of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan. He is a diplomate of both the American Board of Surgery and the American Board of Plastic Surgery.Dr. Vercler received his Bachelor of Science in Biology and Master of Arts in Theological Studies from Wheaton College (IL). He attended medical school at the University of Illinois College of Medicine. He completed general surgery training at Emory University and plastic surgery at the Harvard Plastic Surgery Program. He then did an additional fellowship in Craniofacial Surgery at the University of Michigan.Dr. Vercler has a special interest in medical ethics. He completed a Fellowship in Clinical Ethics at the Emory University Center for Ethics and earned a Masters of Arts degree in Bioethics from Trinity. He currently serves as the Chair of the Pediatric Ethics Committee of C.S. Mott Children’s Hospital and is Co-Chair of the Adult Ethics Committee at Michigan Medicine. Additionally, he is chair of the Bioethics Committee of the Michigan State Medical Society and past chair of both the ASPS Ethics Committee and Ethics Interest Group of the American Cleft Palate-Craniofacial Association.Clinical Specialization:Dr. Vercler focuses primarily on pediatric plastic surgery and craniofacial deformities in children and adults. Dr. Vercler is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Metopic Ridge, Craniosynostosis, Plagiocephaly, Bone Graft, and Osteotomy. Dr. Vercler is board certified in Surgery and Plastic Surgery.

Dr. Magge is a Clinical Professor of Neurosurgery and serves as the Surgical Director of the Pediatric Brain Tumor Program. His clinical practice encompasses all types of pediatric neurosurgery, with particular clinical and research interests in pediatric brain tumors, craniosynostosis (endoscopic and open surgery), and pediatric neurovascular disease (including AVM’s and moyamoya disease). His brain tumor research has focused on finding better treatments for diffuse intrinsic pontine gliomas (DIPG’s) and methods for liquid biopsy. He has been involved in multicenter clinical trials. In the field of craniosynostosis, he has been the principal investigator of a multicenter trial examining long term outcomes of children with craniosynostosis treated with either endoscopic or open surgery. He also started the first endoscopic craniosynostosis surgery program in the Washington, DC area and helped to grow a busy craniosynostosis practice in California. He has authored numerous scholarly papers, and he is a regular speaker at national and international conferences. Dr. Magge works to find the best treatment for each patient in the least invasive method possible.Prior to joining University of Michigan Health, Dr. Magge served as the Director of Neurosurgery and Co-Director of the Children’s Hospital of Orange County Neuroscience Institute and Professor of Clinical Neurosurgery at University of California Irvine. Prior to that, he was a faculty member in the Division of Pediatric Neurosurgery at Children’s National Hospital in Washington, DC, where he started the pediatric neurosurgery fellowship program and served as fellowship director.Dr. Magge grew up in Cincinnati, Ohio, and he attended Harvard College for his undergraduate studies, where he majored in biochemistry. He then obtained his medical degree from Harvard Medical School, graduating in 2001. During medical school, he completed a 1 year Howard Hughes research fellowship at the NIH. He then completed neurosurgery residency training at the University of Pennsylvania in 2008, and fellowship training in pediatric neurosurgery at Boston Children’s Hospital in 2009. Dr. Magge is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Craniosynostosis, Plagiocephaly, Cortical Dysplasia, Craniectomy, and Posterior Fossa Decompression. Dr. Magge is board certified in Neurological Surgery and Pediatric Neurosurgery.

Neena Marupudi is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Marupudi is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. She is also highly rated in 53 other conditions, according to our data. Her clinical expertise encompasses Hydrocephalus, Tethered Cord Syndrome, Chiari Malformation Type 1, Rhizotomy, and Laminectomy. Dr. Marupudi is board certified in Neurological Surgery.

Prior to medical school, Dr. Chang obtained a bachelor’s degree in medieval history at Harvard College, then worked for a publishing house and a health care consulting company, before attending Albany Medical College. After graduation, Dr. Chang moved to Ann Arbor where she completed her pediatrics residency training at the University of Michigan in 2002. She subsequently worked as a pediatric hospitalist as well as a primary care physician, in both community hospitals and academic medical centers, in Ohio, New York, and Michigan. In 2017, she returned to Michigan Medicine in the division of Pediatric Hospital Medicine. Dr. Chang’s interests include newborn medicine, child safety, resident education, and utilization management. Outside of work, she enjoys music, travel, good food, reading, and spending time with her husband and, when they are home, her three high school and college-aged children. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Aplasia Cutis Congenita. Her clinical expertise encompasses Malnutrition, Delayed Growth, Microcephaly, Cerebral Hypoxia, and Myringotomy.